Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer

por Shin, Sol-Bi, Woo, Sang-Uk, Yim, Hyungshin
Publicado 2019

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance

por Shin, Sol-Bi, Kim, Chang-Hyeon, Jang, Hay-Ran, Yim, Hyungshin
Publicado 2020

Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer

por Shin, Sol-Bi, Jang, Hay-Ran, Xu, Rong, Won, Jae-Yeon, Yim, Hyungshin
Publicado 2019

Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer

por Shin, Sol-Bi, Jang, Hay-Ran, Xu, Rong, Won, Jae-Yeon, Yim, Hyungshin
Publicado 2019

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters

por Shin, Sol-Bi, Kim, Dae-Hoon, Kim, Da-Eun, Aldonza, Mark Borris D., Kim, Yoosik, Yim, Hyungshin
Publicado 2021

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC

por Kim, Da-Eun, Shin, Sol-Bi, Kim, Chang-Hyeon, Kim, Yeo-Bin, Oh, Hyun-Ji, Yim, Hyungshin
Publicado 2023

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

por Jang, Hay-Ran, Shin, Sol-Bi, Kim, Chang-Hyeon, Won, Jae-Yeon, Xu, Rong, Kim, Da-Eun, Yim, Hyungshin
Publicado 2021

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

por Jang, Hay-Ran, Shin, Sol-Bi, Kim, Chang-Hyeon, Won, Jae-Yeon, Xu, Rong, Kim, Da-Eun, Yim, Hyungshin
Publicado 2021